The latest news updates from the 2024 Symposium
-
Results from EMERALD trial and key findings from PI3K pathway inhibitor study presented at #SABCS21
Read More: Results from EMERALD trial and key findings from PI3K pathway inhibitor study presented at #SABCS21Wednesday’s General Session featured new data about the oral SERD elacestrant and the effect of tamoxifen on uterine cancer risk.
-
McGuire Award Lecture: Moving to precision care in breast cancer
Read More: McGuire Award Lecture: Moving to precision care in breast cancerOlufunmilayo I. Olopade, MD, FAACR, recounted her lifelong journey through breast cancer genomics during the William L. McGuire Memorial Lecture on Wednesday.
-
Regulatory session covers latest breast cancer treatment approvals
Read More: Regulatory session covers latest breast cancer treatment approvalsA special session on Wednesday reviewed the Food and Drug Administration’s recent approval of pembrolizumab for neoadjuvant and adjuvant treatment, and abemaciclib in the adjuvant setting.
-
Clinical Science Forum to focus on breast cancer-specific use of ablation for oligometastatic disease
Read More: Clinical Science Forum to focus on breast cancer-specific use of ablation for oligometastatic diseaseThe forum, moderated by Steven Chmura, MD, PhD, will include two state-of-the-art presentations covering what is currently known about ablation of oligometastatic disease in breast cancer.
-
Translational Science Forum examines evolving HER2 treatment paradigm
Read More: Translational Science Forum examines evolving HER2 treatment paradigmA panel of researchers and clinicians will join moderator Matthew Ellis, MB, BChir, BSc, PhD, FRCP, to review current evidence related to treatment strategies and outcomes for HER2-positive breast cancer.
-
Scenes from the exhibit hall at SABCS 2021
Read More: Scenes from the exhibit hall at SABCS 2021Time is running out to visit the SABCS 2021 exhibit hall and explore the latest industry advancements in breast cancer prevention and care.
-
Industry events for Friday at SABCS 2021
Read More: Industry events for Friday at SABCS 2021Industry exhibitors will showcase their latest breast cancer treatments, products, and technologies during five onsite presentations scheduled tomorrow.
-
New findings from SAFIR02-BREAST and NeoTRIPaPDL1 trials presented on first day of #SABCS21
Read More: New findings from SAFIR02-BREAST and NeoTRIPaPDL1 trials presented on first day of #SABCS21Tuesday’s General Session featured presentations on abstracts that covered topics such as the clinical utility of molecular tumor profiling and imaging mass cytometry in triple-negative breast cancer.
-
COVID-19 continues to impact breast cancer treatment, trials, and outcomes
Read More: COVID-19 continues to impact breast cancer treatment, trials, and outcomesA session on Tuesday explored how the effects of the pandemic will be felt throughout the breast cancer community for years to come.
-
Brinker Award clinical research recipient highlights key role of genetic testing in breast cancer
Read More: Brinker Award clinical research recipient highlights key role of genetic testing in breast cancerIn recognition of her trailblazing work in clinical cancer genetics, Judy E. Garber, MD, MPH, received the Susan G. Komen® Brinker Award for Scientific Distinction in Clinical Research on Tuesday.